Atlas Trials

Sensitivity to Intravenous Nicotine: Genetic Moderators

Clinical trial NCT00969137 · COMPLETED

Trial details

NCT number
NCT00969137
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Nicotine Dependence
Start date
2009-06-02
Primary completion
2016-06-01
Enrollment
213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.